Lumito partners in national research collaboration – strengthening the company’s position in advanced tissue analysis
Lumito has become a new partner in “Biobarriers – Health, Disorders and Healing”, a government-funded project focusing on the development of new technologies to improve health, as well as diagnostics and treatments. This research and collaboration initiative focuses on the body’s biological barriers, such as skin and mucous membranes in, for example, the gastrointestinal tract. […]
Lumito and Truly Labs Take the Next Step Together Following Successful Pilot Study – Preparing for Customer Sample Analysis
Lumito AB today announces that its collaboration with Truly Labs has resulted in the completion of a pilot study showing positive results. The next step will be validation with customer samples. The outcomes of this validation will form the basis for Truly Labs’ offering of tissue analysis using Lumito’s product Scizys to its customers. The […]
Concept Life Sciences confirms Scizys’ compatibility with automated staining – ready for customer sample testing
Lumito AB (publ) announces today that the UK-based contract research organisation Concept Life Sciences has completed the first stage of the evaluation of Lumito's product, Scizys Erbium kit and Scizys scanner. The positive outcome marks a significant step forward in bringing Lumito’s high-sensitivity tissue analysis solution to the market and is strengthening the position of […]
Further Insights from Scientific Advisory Board Meeting – Confirms the Potential of Lumito’s Innovative Solution for Quantitative Tissue Analysis
At Lumito’s Scientific Advisory Board (SAB) meeting held on June 9, the SAB confirmed the uniqueness and potential of Lumito’s innovative solution, Scizys, for quantitative tissue analysis. Additionally, the advisors were unified in the view that Lumito has a product that will meet the needs of the pharmaceutical industry. The SAB, where a few have […]
Lumito’s Scientific Advisory Board Meeting Held and Additional Key Opinion Leader Joins
Following the establishment of its Scientific Advisory Board (SAB) announced on 5 June 2025, the SAB held a meeting this week, where the uniqueness of Lumito’s solution, Scizys, was confirmed and reaffirmed as a promising technology with the potential to lead the way in quantitative tissue analysis and pathology. Lumito are pleased to announce that […]
Lumito establishes Scientific Advisory Board with leading international experts in drug development, pathology, and oncology
Lumito has established a Scientific Advisory Board (SAB) to primarily support its ongoing commercialisation and, in the longer term, to strengthen the company’s strategic efforts toward a product for clinical use. The board comprises globally recognised experts in pathology, diagnostics, oncology, digitalisation, and drug development, with extensive experience spanning academia, healthcare, and the pharmaceutical industry. […]
Lumito featured at AACR 2025
The AACR Annual Meeting (American Association for Cancer Research) is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. Lumito gained valuable visibility through a presentation by Professor Paul Waring at Akoya’s Spotlight Theatre, […]